Company intelligence / Profile preview

HeartLab

Auckland, Auckland, New Zealandheartlab.com ↗

Ownership: Private
Development stage: Commercial

Overview

HeartLab has developed an AI-powered, cloud-based platform that streamlines the acquisition, analysis, sharing, and reporting of echocardiograms. The system improves efficiency for cardiac care teams by automating repetitive tasks in image measurement/reporting and enabling real-time collaboration. The company is expanding internationally with a focus on the U.S., New Zealand, and Australia markets. No clinical trial results are relevant as this is not a therapeutic product.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Medical Imaging

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of latest available information.

Beyond the preview

Go deeper on HeartLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeartLab.

Explore the full profile